logo-loader
RNS
Optima Health PLC

Optima Health PLC - Director/PDMR Shareholding

RNS Number : 1102C
Optima Health PLC
28 April 2026
 

28 April 2026

Optima Health plc

("Optima", the "Company", and, together with its subsidiaries, the "Group")

Director / PDMR Dealings

Optima Health (AIM: OPT), the UK's leading provider of technology enabled corporate health and wellbeing solutions, announces that following Admission of the Open Offer shares on 23 April 2026, the Directors / PDMRs, Julie Robertson, Jonathan Thomas, Heidi Giles, Simon Arnold, Adam Councell and Joanne Newey have subscribed for an aggregate of 51,560 Open Offer Shares, representing approximately 0.05% of the Company's enlarged issued share capital.

Details of the Ordinary Shares held by each of the Directors/PDMRs are detailed below:

Director/PDMR

Current shareholding

% of issued share capital

Shareholding immediately following Admission

% of the enlarged issued share capital following Admission

Julia Robertson

21,500 Ordinary Shares

0.02

26,343

0.02

Jonathan Thomas

218,356 Ordinary Shares

0.25

229,856

0.21

Heidi Giles

83,228 Ordinary Shares

0.09

92,000

0.08

Simon Arnold

20,451 Ordinary Shares

0.02

32,100

0.03

Adam Councell

34,608 Ordinary Shares

0.04

42,404

0.04

Joanne Newey

84,080 Ordinary Shares

0.09

91,080

0.08

Capitalised terms used but not defined in this announcement shall have the meaning ascribed to such terms in the Circular unless the context requires otherwise.

               

Optima Health

Jonathan Thomas, CEO

Heidi Giles, CFO

 

+44(0) 33 0008 5113

media@OptimaHealth.co.uk

Nominated Adviser and Joint Corporate Broker

Panmure Liberum Limited

Emma Earl / Will Goode/ Mark Rogers

Rupert Dearden

Debt Advisory (sole debt adviser on the transaction):

Dan Howlett / Ben Handler

 

 

+44 (0)20 3100 2000

Joint Corporate Broker

Cavendish Capital Markets

Geoff Nash / Ben Jeynes / George Lawson

Julian Morse / Michael Johnson/ Nigel Birks

+ 44 (0)20 7220 0500

 



UK Financial PR Adviser

ICR Healthcare

Mary-Jane Elliott / Angela Gray / Lindsey Neville

optimahealth@icrinc.com

 


About Optima

Optima is the UK's leading provider of occupational health and wellbeing services, directly influencing and improving people's lives for 25 years. Optima's incredible team of professionals quickly and effectively encapsulate client's needs, supporting organisations of all shapes and sizes. Through tailored solutions and innovative systems, Optima offers unparalleled clinical expertise to its clients. These solutions ensure that processes are simple and allow its clients to spend more time focusing on their employees driving a healthy, high-performing workplace. For more information visit www.optima health.co.uk.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

1.     Julia Robertson

2.     Jonathan Thomas

3.     Heidi Giles

4.     Simon Arnold

5.     Adam Councell

6.     Joanne Newey

2

 

Reason for the notification

 

a)

 

Position/status

 

 

1.     Non-Executive Chairman

2.     Chief Executive Officer

3.     Chief Financial Officer

4.     Non-Executive Director

5.     Non-Executive Director

6.     Chief Commercial Officer (PDMR)

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Optima Health plc

b)

 

LEI

 

 

213800TOPWJSRCW4ON08

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of £0.01 each



Identification code

GB00BRSCY602



b)

 

Nature of the transaction

 

 

Purchase of shares

c)

 

Price(s) and volume(s)







Purchase Price

Volume




175 pence per Ordinary Share

1.     4,843

2.     11,500

3.     8,772

4.     11,649

5.     7,796

6.     7,000







d)

 

Aggregated information




- Aggregated volume

51,560 shares


175.00 pence

- Price




e)

 

Date of the transaction

 

 

23 April 2026

f)

 

Place of the transaction

 

 

London Stock Exchange, AIM Market

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSEDESWEMSEDL
NO INVESTMENT ADVICE

Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.

Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.

In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.

The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

FOR OUR FULL DISCLAIMER CLICK HERE

Optima Health, Impact Healthcare REIT, Seeing Machines, ATOME, Tertiary...

Optima Health PLC (AIM:OPT, OTC:OHLTF, FRA:J3N) says it's starting the new year with strong momentum and sticking to its growth targets. It's chasing £200 million in revenue, backed by a huge new Armed Forces recruitment contract worth up to £210 million. Read more Impact Healthcare REIT PLC...

on 08/17/2026

3 min read